2023 Brain Tumour Grant Funding
Latest grant funding for brain tumour research and equipment for 2023
We are ecstatic to announce our latest grant funding. This year, with your help, we are able to contribute a total of $1,284,337 to 27 different grants and equipment projects.
And are excited to announce a total of $827,684 for life-changing brain tumour research projects as part of our latest grant round! This is only possible thanks to our amazing donors who give to truly make a difference and fight against this life-impacting disease.
Pictured left to right:
A Prof Lisa Ebert - Exploiting blood vessels as conduits for the entry of therapeutic CAR-T cells into brain tumours
A Prof Lisa Ebert - Developing new immune-based therapies for brain cancer - James & Diana Ramsay Foundation
Dr Nirmal Robinson - Targeting CD47 and metabolic vulnerabilities to treat glioblastoma
Prof Michael Brown - Improving immunotherapy for aggressive brain cancer using cytokine boosting
Prof Michael Brown - Making immunotherapy for childhood brain cancer more effective - NRF Paediatric Fund
Dr Briony Gliddon - Developing a preclinical model of glioblastoma for drug discovery and improved translational research
Dr Briony Gliddon - Equipment: VETSCAN HM5 Haematology Analyser
Dr Tessa Gargett - Equipment: The CliniMACS Plus device for closed system cell selection for cell therapy manufacturing
A Prof Cedric Bardy - Comparing the function of lab-grown human neurons to the adult human brain
Pictured left to right:
Prof Stuart Pitson - Developing Advanced Pre-Clinical Models of Paediatric Brain Cancers - Wilkins Family Foundation
Prof Stuart Pitson - Developing Advanced Pre-Clinical Models of Paediatric Brain Cancers - Harvey Foundation
Assoc Prof Simon Conn - Precision medical approaches for the treatment of gliomas with cannabinoids - Perpetual
A Prof Jordan Hansford - South Australian Paediatric Brain Cancer Biobank - NRF Paediatric Fund
Dr Manjun Li - Improving GD2-targeting immunotherapy for glioblastoma
A Prof Peter Gorayski - Paediatric Radiation Therapy with AI-based Segmentation for Enhanced Treatment Planning (PRAISE)
Dr Chloe Shard - Targeting glutamine metabolism: a new therapeutic avenue for glioblastoma.
